Contact
Please use this form to send email to PR contact of this press release:
Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes
TO:
Please use this form to send email to PR contact of this press release:
Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes
TO: